Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 9/2018

24-05-2018

Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis

Auteurs: S. J. Bartlett, A. K. Gutierrez, A. Butanis, V. P. Bykerk, J. R. Curtis, S. Ginsberg, A. L. Leong, A. Lyddiatt, W. B. Nowell, A. M. Orbai, K. C. Smith, C. O. Bingham 3rd

Gepubliceerd in: Quality of Life Research | Uitgave 9/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Fatigue is frequent and often severe and disabling in RA, and there is no consensus on how to measure it. We used online surveys and in-person interviews to evaluate PROMIS Fatigue 7a and 8a short forms (SFs) in people with RA.

Methods

We recruited people with RA from an online patient community (n = 200) and three academic medical centers (n = 84) in the US. Participants completed both SFs then rated the comprehensiveness and comprehensibility of the items to their fatigue experience. Cognitive debriefing of items was conducted in a subset of 32 clinic patients. Descriptive statistics were calculated, and associations were evaluated using Pearson and Spearman correlation coefficients.

Results

Mean SF scores were similar (p ≥ .61) among clinic patients reflecting mild fatigue (i.e., 54.5–55.9), but were significantly higher (p < .001) in online participants. SF Fatigue scores correlated highly (r ≥ 0.82; p < .000) and moderately with patient assessments of disease activity (r ≥ 0.62; p = .000). Most (70–92%) reported that the items “completely” or “mostly” reflected their experience. Almost all (≥ 94%) could distinguish general fatigue from RA fatigue. Most (≥ 85%) rated individual items questions as “somewhat” or “very relevant” to their fatigue experience, averaged their fatigue over the past 7 days (58%), and rated fatigue impact versus severity (72 vs. 19%). 99% rated fatigue as an important symptom they considered when deciding how well their current treatment was controlling their RA.

Conclusions

Results suggest that items in the single-score PROMIS Fatigue SFs demonstrate content validity and can adequately capture the wide range of fatigue experiences of people with RA.
vorige artikel Cross-national health comparisons using the Rasch model: findings from the 2012 US Health and Retirement Study and the 2012 Mexican Health and Aging Study
volgende artikel Validity of the PROMIS depression and anxiety common metrics in an online sample of Australian adults
Literatuur
1.
Bartlett, S. J., Hewlett, S., Bingham 3rd, C. O., Woodworth, T. G., Alten, R., Pohl, C., et al. (2012). Identifying core domains to assess flare in rheumatoid arthritis: An OMERACT International patient and provider combined Delphi consensus. Annals of the Rheumatic Diseases, 71(11), 1855–1860.CrossRefPubMed
2.
Hewlett, S., Cockshott, Z., Byron, M., Kitchen, K., Tipler, S., Pope, D., et al. (2005). Patients’ perceptions of fatigue in rheumatoid arthritis: Overwhelming, uncontrollable, ignored. Arthritis and Rheumatism, 53(5), 697–702.CrossRefPubMed
3.
4.
Kirwan, J. R., & Hewlett, S. (2007). Patient perspective: Reasons and methods for measuring fatigue in rheumatoid arthritis. The Journal of Rheumatology, 34(5), 1171–1173.PubMed
5.
Kvien, T. K. (2004). Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics, 22(2), 1–12.CrossRefPubMed
6.
Alten, R., Pohl, C., Choy, E. H., Christensen, R., Furst, D. E., Hewlett, S. E., et al. (2011). Developing a construct to evaluate flares in rheumatoid arthritis: A conceptual report of the OMERACT RA Flare Definition Working Group. The Journal of Rheumatology, 38(8), 1745–1750.CrossRefPubMed
7.
Kirwan, J. R., Minnock, P., Adebajo, A., Bresnihan, B., Choy, E., de Wit, M., et al. (2007). Patient perspective: Fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. The Journal of Rheumatology, 34(5), 1174–1177.PubMed
8.
Aletaha, D., Landewe, R., Karonitsch, T., Bathon, J., Boers, M., Bombardier, C., et al. (2008). Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Care & Research, 59(10), 1371–1377.CrossRef
9.
Felson, D. T., Smolen, J. S., Wells, G., Zhang, B., van Tuyl, L. H., Funovits, J., et al. (2011). American College of Rheumatology/European League against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis & Rheumatology, 63(3), 573–586.CrossRef
10.
Khanna, D., Krishnan, E., Dewitt, E. M., Khanna, P. P., Spiegel, B., & Hays, R. D. (2011). Patient-Reported Outcomes Measurement Information System (PROMIS(R))—the future of measuring patient reported outcomes in rheumatology. Arthritis Care Research (Hoboken), 63(S11), S486–S90.CrossRef
11.
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.CrossRefPubMedPubMedCentral
12.
Christodoulou, C., Junghaenel, D. U., DeWalt, D. A., Rothrock, N., & Stone, A. A. (2008). Cognitive interviewing in the evaluation of fatigue items: Results from the Patient-Reported Outcomes Measurement Information System (PROMIS). Quality of life research: An international journal of quality of life aspects of treatment. Care and Rehabilitation, 17(10), 1239–1246.
13.
Lai, J. S., Cella, D., Choi, S., Junghaenel, D. U., Christodoulou, C., Gershon, R., et al. (2011). How item banks and their application can influence measurement practice in rehabilitation medicine: A PROMIS fatigue item bank example. Archives of Physical Medicine and Rehabilitation, 92(10 Suppl), S20–S27.
14.
Cella, D., Lai, J. S., Jensen, S. E., Christodoulou, C., Junghaenel, D. U., Reeve, B. B., et al. (2016). PROMIS fatigue item bank had clinical validity across diverse chronic conditions. Journal of Clinical Epidemiology, 73, 128–134.CrossRefPubMedPubMedCentral
15.
Bartlett, S. J., Orbai, A. M., Duncan, T., DeLeon, E., Ruffing, V., Clegg-Smith, K., et al. (2015). Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis. PLoS ONE, 10(9), e0138543.CrossRefPubMedPubMedCentral
16.
Bingham 3rd, C. O., Noonan, V., Auger, C., Feldman, D., Ahmed, S., & Bartlett, S. J. (2017) Montreal Accord on Patient-Reported Outcomes use series—paper 4: Patient Reported Outcomes (PRO) can inform clinical decision-making in chronic care. Journal of Clinical Epidemiology, 89, 136–141.CrossRef
17.
Bingham 3rd, C. O., Bartlett, S. J., Merkel, P. A., Mielenz, T. J., Pilkonis, P. A., Edmundson, L., et al. (2016). Using Patient-Reported Outcomes and PROMIS in research and clinical applications: Experiences from the PCORI pilot projects. Quality of Life Research, 25(8), 2109–2116.CrossRefPubMedPubMedCentral
18.
19.
Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., et al. (2011). Content validity–establishing and reporting the evidence in newly developed Patient-Reported Outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—assessing respondent understanding. Value in Health, 14(8), 978–988.CrossRefPubMed
20.
Karlson, E. W., Sanchez-Guerrero, J., Wright, E. A., Lew, R. A., Daltroy, L. H., Katz, J. N., et al. (1995). A connective tissue disease screening questionnaire for population studies. Annals of Epidemiology, 5(4), 297–302.CrossRefPubMed
21.
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., & Bingham 3rd, C. O. (2010). 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatology, 62(9), 2569–2581.CrossRef
22.
Taylor, W., Gladman, D., Helliwell, P., Marchesoni, A., Mease, P., Mielants, H., et al. (2006). Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis & Rheumatology, 54(8), 2665–2673.CrossRef
23.
Deng, N., Guyer, R., & Ware, J. E. (2015). Energy, fatigue, or both? A bifactor modeling approach to the conceptualization and measurement of vitality. Quality of Life Research, 24(1), 81–93.CrossRefPubMed
24.
Hewlett, S., Dures, E., & Almeida, C. (2011) Measures of fatigue: Bristol rheumatoid arthritis fatigue multi-dimensional questionnaire (BRAF MDQ), Bristol rheumatoid arthritis fatigue numerical rating scales (BRAF NRS) for severity, effect, and coping, Chalder fatigue questionnaire (CFQ), checklist individual strength (CIS20R and CIS8R), fatigue severity scale (FSS), functional assessment chronic illness therapy (fatigue) (FACIT‐F), multi-dimensional assessment of fatigue (MAF), multi-dimensional fatigue inventory (MFI), pediatric quality of life (PEDSQL) multi-dimensional fatigue scale, profile of fatigue (PROF), short form 36 vitality subscale (SF-36 VT), and visual analog scales (VAS). Arthritis Care & Research, 63 (Suppl 11), S263–S286.
25.
Oude Voshaar, M. A., Ten Klooster, P. M., Bode, C., Vonkeman, H. E., Glas, C. A., Jansen, T., et al. (2015). Assessment of fatigue in rheumatoid arthritis: A psychometric comparison of single-item, multiitem, and multidimensional measures. Journal of Rheumatology, 42(3), 413–420.CrossRefPubMed
26.
Wolfe, F. (2004). Fatigue assessments in rheumatoid arthritis: Comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. Journal of Rheumatology, 31(10), 1896–1902.PubMed
27.
Simons, G., Belcher, J., Morton, C., Kumar, K., Falahee, M., Mallen, C. D., et al. (2017). Symptom recognition and perceived urgency of help-seeking for rheumatoid arthritis and other diseases in the general public: A mixed method approach. Arthritis Care & Research, 69(5), 633–641.CrossRef
28.
Shiyanbola, O. O., & Farris, K. B. (2010). Variation in patients’ and pharmacists’ attribution of symptoms and the relationship to patients’ concern beliefs in medications. Research in Social and Administrative Pharmacy, 6(4), 334–344.CrossRefPubMed
29.
Nijrolder, I., Leone, S. S., & van der Horst, H. E. (2015). Explaining fatigue: An examination of patient causal attributions and their (in)congruence with family doctors’ initial causal attributions. European Journal of General Practice, 21(3), 164–169.CrossRefPubMed
30.
Horne, R., & Weinman, J. (1999). Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47(6), 555–567.CrossRefPubMed
31.
Stack, R. J., Shaw, K., Mallen, C., Herron-Marx, S., Horne, R., & Raza, K. (2012). Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: A systematic synthesis of qualitative literature. Annals of the Rheumatic Diseases, 71(4), 493–497.CrossRefPubMed
32.
Tweehuysen, L., van den Bemt, B. J. F., van Ingen, I. L., de Jong, A. J. L., van der Laan, W. H., van den Hoogen, F. H. J., et al. (2018). Subjective complaints as the main reason for biosimilar discontinuation after open-label transition from reference infliximab to Biosimilar Infliximab. Arthritis & Rheumatology, 70(1), 60–68.CrossRef
33.
Rose, M., Bjorner, J. B., Gandek, B., Bruce, B., Fries, J. F., & Ware, J. E. (2014). Jr. The PROMIS physical function item bank was calibrated to a standardized metric and shown to improve measurement efficiency. Journal of Clinical Epidemiology, 67(5), 516–526.CrossRefPubMedPubMedCentral
34.
Kirwan, J. R., Minnock, P., Adebajo, A., Bresnihan, B., Choy, E., de Wit, M., et al. (2007). Patient perspective: Fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. Journal of Rheumatology, 34(5), 1174–1177.PubMed
35.
Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.CrossRefPubMed
36.
Webster, K., Cella, D., & Yost, K. (2003). The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties, applications, and interpretation. Health and Quality of Life Outcomes, 1, 79–79.CrossRefPubMedPubMedCentral
37.
Cella, D., Yount, S., Sorensen, M., Chartash, E., Sengupta, N., & Grober, J. (2005). Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. The Journal of Rheumatology, 32(5), 811–819.PubMed
38.
Allaire, S., Wolfe, F., Niu, J., & Lavalley, M. P. (2008). Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. Arthritis Care & Research, 59(4), 474–480.CrossRef
39.
Nicklin, J., Cramp, F., Kirwan, J., Greenwood, R., Urban, M., & Hewlett, S. (2010). Measuring fatigue in rheumatoid arthritis: A cross-sectional study to evaluate the Bristol rheumatoid arthritis fatigue multi-dimensional questionnaire, visual analog scales, and numerical rating scales. Arthritis Care & Research, 62(11), 1559–1568.CrossRef
40.
41.
Mesa, R. A., Gotlib, J., Gupta, V., Catalano, J. V., Deininger, M. W., Shields, A. L., et al. (2013). Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other Patient-Reported Outcomes in COMFORT-I: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Oncology, 31(10), 1285–1292.CrossRefPubMedPubMedCentral
42.
Wild, D., Eremenco, S., Mear, I., Martin, M., Houchin, C., Gawlicki, M., et al. (2009). Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: The ISPOR Patient-Reported Outcomes translation and linguistic validation good research practices task force report. Value Health, 12(4), 430–440.CrossRefPubMed
43.
Alonso, J., Bartlett, S. J., Rose, M., Aaronson, N. K., Chaplin, J. E., Efficace, F., et al. (2013). The case for an international Patient-Reported Outcomes Measurement Information System (PROMIS®) initiative. Health and Quality of Life Outcomes, 11, 210.CrossRefPubMedPubMedCentral
Metagegevens
Titel
Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis
Auteurs
S. J. Bartlett
A. K. Gutierrez
A. Butanis
V. P. Bykerk
J. R. Curtis
S. Ginsberg
A. L. Leong
A. Lyddiatt
W. B. Nowell
A. M. Orbai
K. C. Smith
C. O. Bingham 3rd
Publicatiedatum
24-05-2018
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 9/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-1880-x

Andere artikelen Uitgave 9/2018

Quality of Life Research 9/2018 Naar de uitgave

OriginalPaper

Cross-national health comparisons using the Rasch model: findings from the 2012 US Health and Retirement Study and the 2012 Mexican Health and Aging Study

OriginalPaper

Trajectory of health-related quality of life and its determinants in patients who underwent lumbar spine surgery: a 1-year longitudinal study

Brief Communication

Refining and supplementing candidate measures of psychological well-being for the NIH PROMIS®: qualitative results from a mixed cancer sample

OriginalPaper

SF-6D population norms for the Hong Kong Chinese general population

OriginalPaper

Validity of the EQ–5D–5L and reference norms for the Spanish population

OriginalPaper

Evaluation of the internal and external responsiveness of Short Form-12 Health Survey version 2 (SF-12v2) in patients with type 2 diabetes mellitus